Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Shares Issued (2016 - 2025)

Fortress Biotech has reported Shares Issued over the past 13 years, most recently at $368000.0 for Q4 2025.

  • Quarterly results put Shares Issued at $368000.0 for Q4 2025, up 8.24% from a year ago — trailing twelve months through Dec 2025 was $2.6 million (down 29.11% YoY), and the annual figure for FY2025 was $2.6 million, down 29.11%.
  • Shares Issued for Q4 2025 was $368000.0 at Fortress Biotech, down from $1.3 million in the prior quarter.
  • Over the last five years, Shares Issued for FBIO hit a ceiling of $36.0 million in Q1 2025 and a floor of -$35.0 million in Q2 2025.
  • Median Shares Issued over the past 5 years was $447000.0 (2023), compared with a mean of $758684.2.
  • Peak annual rise in Shares Issued hit 3926.85% in 2025, while the deepest fall reached 3950.0% in 2025.
  • Fortress Biotech's Shares Issued stood at -$2.5 million in 2021, then surged by 112.27% to $303000.0 in 2022, then tumbled by 104.95% to -$15000.0 in 2023, then surged by 2366.67% to $340000.0 in 2024, then increased by 8.24% to $368000.0 in 2025.
  • The last three reported values for Shares Issued were $368000.0 (Q4 2025), $1.3 million (Q3 2025), and -$35.0 million (Q2 2025) per Business Quant data.